Drug

Histamine-2 Receptor Antagonist clinical trials

studies test it: 3
open now: 1
in phase 3: 0
first study started: 2012

Keep track of what changes. Save the Histamine-2 Receptor Antagonist studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

histamine-2 receptor antagonist: 1

Studies by the year they started

3 studies that test it; most in 2012 (2)

Studies that test Histamine-2 Receptor Antagonist, by start year
Year	Studies
2012	2
2023	1

By phase

A phase 1/2 study counts in both.

Phase 1: 1
Phase 2: 1
No phase: 2

What it is tested for

Each study’s main condition, where its own words name it.

Peptic Ulcer: 2
Esophageal Squamous Cell Carcinoma: 1

Who runs them

Industry 1 · Other 2

Kaohsiung Veterans General Hospital. (2) · Merck Sharp & Dohme LLC (1)

Often tested with

Tested in the same studies.

Paclitaxel (1) · Irinotecan (1) · Pembrolizumab (1) · Sacituzumab tirumotecan (1) · Histamine Antagonists (1) · Acetaminophen (1) · Dexamethasone (1) · Steroids (1)

Related medicines

As reviewed, each with the page that says it.

One of Antacids source

Studies

Open first, then newest update. How each study uses Histamine-2 Receptor Antagonist is read from its arms, and is right about nine times in ten.

Testing it · 3

Given in every arm · 5 — Histamine-2 Receptor Antagonist is usual care beside what is tested